Research
0
Over 180 companies from different regions across the globe presently claim to provide services for the development of companion diagnostic.

It is estimated that around 80% of innovator companies rely on external companion diagnostic developers, mostly owing to the lack of the required in-house ...

0
The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future ...

0
The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Roots Analysis

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion ...

0
The “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report features an extensive study of the current market landscap.

To order this 170+ page report, please visit this link Key Inclusions A detailed review of the overall landscape of fragment-based drug discovery ...

0
Over 85 firms are involved in providing fragment-based drug discovery-related services.

According to experts in this field, fragment-based drug discovery solutions have facilitated the identification of viable pharmacological leads against ...

0
The fragment-based drug discovery market is projected to grow at an annualized rate of ~10%, till 2030

Roots Analysis has done a detailed study on Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030, covering key aspects of the ...

0
The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as ...

0
Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030

Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach ...

0
The “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report features an extensive study of the current market landscape

To order this detailed 350+ page report, please visit this link   Key Inclusions A detailed assessment of the current market landscape, ...

0
More than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation

Over time, significant strides have been made in immune checkpoint research, resulting in the discovery of several inhibitory (LAG-3, TIM-3, TIGIT, VISTA and ...

Web Article Services
Logo
Shopping cart